Skip to main content
. 2023 Jul 4;10(4):627–637. doi: 10.3233/JND-221658

Table 4.

Total and Respiratory adverse events

Early NIV Standard NIV P
R. events, n 12 24 0.34*
R. patients, n (%) 7 (35) 15 (68) 0.065**
Severity, n (%):
Mild/Moderate 10 (83) 15 (62)
Severe 2 (17) 9 (38) 0.07**

*Chi2; **Fisher; R. events: number of total respiratory events; R. patients: number of patients with respiratory events.